FDA Focuses On Weeding Out Deficient PMAs
This article was originally published in The Gray Sheet
Executive Summary
A draft guidance document designates “acceptance” criteria that when not met by a PMA will allow a reviewer to send the submission back to the sponsor more quickly.
You may also be interested in...
FDA Finalizes 510(k), PMA, eCopy Guidances
FDA spells out its acceptance policies for 510(k) and PMA submissions, as well as guidelines for submitting electronic copies of submissions. The guidances all aim to make the device review process more efficient and speedy.
Industry Praises PMA-Acceptance Draft Guidance, But Offers A Few Suggestions
Companies are generally happy with FDA’s July 31 draft guidance describing a 15-day "acceptance review" that FDA staff will perform to quickly check that a PMA submission meets minimum requirements.
FDA Aims To Reduce 510(k) Review Times With New Submission Acceptance Process
Draft guidance outlines criteria that 510(k) submissions must meet before the agency begins its substantive review.